- The trend backdrop is active with a 9-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
MED
GER
Week ended 07 Aug 2026
Weekly Investor Report
MEDICLIN Aktiengesellschaft · Healthcare · Medical Care Facilities
Latest close
4.30 EUR
4.4%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 13.7% above the Trend Line and sits at 93.6% of its 52-week range. The latest completed week returned 4.4%, after a 6.4% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.
Setup score
72
out of 100
Latest Close
4.30 EUR
7 Aug 2026
1W Return
4.4%
latest completed week
4W Return
6.4%
short-term follow-through
12W Return
22.1%
quarterly tape
Trend Breadth
80.8%
42 of 52 weeks active
Volume Ratio
5.0x
vs 13-week average
- Next-week expectancy is negative at 43.94% based on similar historical setup states.
- 2 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
4.4%
Latest completed week; four-week move 6.4%.
Indicator stack
76/73
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.94%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 13.7% above the Trend Line and sits at 93.6% of its 52-week range. The latest completed week returned 4.4%, after a 6.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 5.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8312-week average 0.63
12-week confirmation
Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.83Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 6.4% over four weeks, 22.1% over 12 weeks, and 43.9% over one year. The current trend has remained active for 9 consecutive weeks.
Performance by holding period
Active trend streak9 weeks
Active weeks in one year42
Trend breadth80.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.04Latest activity-pressure read.
Pressure change50.5%Four-week change in activity pressure.
Leadership10.92Latest relative-leadership reading.
RS change-8.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength100/100Blend of value, momentum, and quality. Underlying universe rank 1; rank 1 is best.
Value98/100Relative valuation strength. Underlying universe rank 3; rank 1 is best.
Quality85/100Profitability and accounting quality. Underlying universe rank 16; rank 1 is best.
Momentum81/100Medium-term price momentum. Underlying universe rank 20; rank 1 is best.
Growth44/100Revenue and earnings growth. Underlying universe rank 57; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework81/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 7.0x Price divided by trailing earnings.
- Price / sales
- 0.3x Market value relative to trailing revenue.
- EV / EBITDA
- 4.1x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 9.7% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 84.8% Gross profit retained from each unit of revenue.
- Operating margin
- 9.4% Operating profit retained from revenue.
- Free-cash-flow margin
- 6.2% Free cash flow generated from revenue.
- Return on invested capital
- 10.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 4.8% Latest one-year revenue growth.
- EPS growth
- 2.6% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 42.2% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 8/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.9% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.9% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.4x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-2.3%Distance below the 52-week high.
13-week volatility4.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2611 weeks finished lower.
Best week+12.3%Week of 5 Jun.
Worst week-7.3%Week of 13 Feb.
Latest week+4.4%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains8
Flat weeks1
Modest losses7
Sharp losses4
Recent vol4.0%13-week weekly-return volatility.
Base vol4.0%52-week weekly-return volatility.
Up/down split28/22Count of positive and negative weeks in the 52-week window.
Average skew3.7% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDE Healthcare
4-week rank22 / 78
Group average1.4%
Trend breadth39.7%
Trend39.7%active weekly trend signals
MD69.2%positive activity pressure
RS34.6%positive relative leadership
Four-week leaders
IndustryDE Medical Care Facilities
4-week rank4 / 7
Group average2.5%
Trend breadth57.1%
Trend57.1%active weekly trend signals
MD71.4%positive activity pressure
RS42.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape69/100
Trend, activity pressure, participation, and risk combine to a 69/100 tape read.
Indicator analysis73/100Latest 12-week confirmation: trend 9/12, activity pressure 9/12, relative leadership 12/12.
Activity pressure 0.83; 2 reversal markers Next-Week ExpectancyNegative 43.94%Next-week expectancy is negative with a 43.94% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors90/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 71; Small Cap Core rank 8 SVQF81/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 72.0 of 375 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
MEDICLIN reports a solid first half of 2026 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 4.30 EUR | 4.4% | 3.78 EUR | 2.96 EUR | 1.04 | 10.92 | 81.2K | On |
| 31 Jul 2026 | 4.12 EUR | -3.3% | 3.76 EUR | 2.95 EUR | 0.89 | 9.71 | 23.7K | On |
| 24 Jul 2026 | 4.26 EUR | 2.4% | 3.74 EUR | 2.94 EUR | 0.80 | 16.35 | 14.4K | On |
| 17 Jul 2026 | 4.16 EUR | 3.0% | 3.72 EUR | 2.93 EUR | 0.70 | 15.61 | 10.8K | On |
| 10 Jul 2026 | 4.04 EUR | 0.5% | 3.70 EUR | 2.93 EUR | 0.69 | 11.92 | 11.9K | On |
| 3 Jul 2026 | 4.02 EUR | 1.5% | 3.69 EUR | 2.92 EUR | 0.68 | 8.88 | 4.2K | On |
| 26 Jun 2026 | 3.96 EUR | -2.5% | 3.68 EUR | 2.91 EUR | 0.68 | 12.56 | 1.8K | On |
| 19 Jun 2026 | 4.06 EUR | 0.0% | 3.66 EUR | 2.91 EUR | 0.52 | 14.50 | 2.0K | On |
| 12 Jun 2026 | 4.06 EUR | -3.3% | 3.64 EUR | 2.90 EUR | 0.19 | 16.68 | 7.9K | On |
| 5 Jun 2026 | 4.20 EUR | 12.3% | 3.62 EUR | 2.89 EUR | -0.22 | 20.76 | 874 | Off |
| 29 May 2026 | 3.74 EUR | 5.0% | 3.60 EUR | 2.88 EUR | -0.55 | 6.77 | 21.0K | Off |
| 22 May 2026 | 3.56 EUR | 1.1% | 3.59 EUR | 2.88 EUR | -0.88 | 2.98 | 21.2K | Off |
| 15 May 2026 | 3.52 EUR | 0.6% | 3.59 EUR | 2.87 EUR | -1.09 | 6.14 | 10.4K | Off |
| 8 May 2026 | 3.50 EUR | 4.7% | 3.58 EUR | 2.87 EUR | -1.05 | 4.22 | 66.0K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.